Biogen Inc. (BIIB)

NASDAQ: BIIB · Real-Time Price · USD

121.00

-0.08 (-0.07%)

At close: May 01, 2025, 3:59 PM

120.93

-0.06%

After-hours: May 01, 2025, 04:02 PM EDT

Biogen Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	9.68B	9.84B	10.17B	10.98B	13.44B	14.38B	13.45B	12.27B	11.45B
Cost of Revenue	n/a	2.53B	2.28B	2.11B	1.81B	1.96B	1.82B	1.63B	1.48B
Gross Profit	9.68B	7.3B	7.9B	8.87B	11.64B	12.42B	11.64B	10.64B	9.97B
Operating Income	5.23B	2.1B	2.32B	2.84B	4.55B	7.04B	5.89B	5.34B	5.15B
Interest Income	n/a	276.5M	89.3M	11M	42M	120M	112.5M	78.5M	63.4M
Pretax Income	1.91B	1.3B	3.59B	1.75B	5.05B	7.13B	5.9B	5.13B	4.93B
Net Income	1.63B	1.16B	3.05B	1.56B	4B	5.89B	4.43B	2.54B	3.7B
Selling & General & Admin	2.4B	2.55B	2.4B	2.67B	2.5B	2.37B	2.11B	1.94B	1.95B
Research & Development	2.04B	2.7B	2.23B	2.5B	3.99B	2.28B	2.6B	2.25B	1.97B
Other Expenses	n/a	n/a	358.5M	888.5M	697.7M	731.5M	11M	-215.4M	-217.4M
Operating Expenses	4.45B	6.01B	4.99B	6.06B	7.19B	5.39B	5.64B	5.12B	4.32B
Interest Expense	n/a	246.9M	246.6M	253.6M	222.5M	187.4M	200.6M	250.8M	260M
Selling & Marketing Expenses	n/a	71.4M	54.1M	98.7M	111.8M	79.2M	90.2M	75.2M	106.3M
Cost & Expenses	7.77B	7.74B	7.27B	8.17B	9B	7.34B	7.45B	6.75B	5.8B
Income Tax Expense	273.8M	135.3M	632.8M	52.5M	992.3M	1.16B	1.43B	2.46B	1.24B
Shares Outstanding (Basic)	145.7M	144.7M	145.3M	149.1M	160.9M	187.1M	204.9M	212.6M	218.4M
Shares Outstanding (Diluted)	145.9M	145.6M	146M	149.6M	161.3M	187.4M	205.3M	213M	218.8M
EPS (Basic)	11.20	8.02	20.97	10.44	24.86	31.47	21.62	11.94	16.96
EPS (Diluted)	11.19	7.97	20.87	10.40	24.80	31.42	21.58	11.92	16.93
EBITDA	n/a	2.38B	4.36B	2.49B	5.73B	7.78B	6.75B	6.1B	5.88B
EBIT	n/a	1.88B	3.84B	2B	5.27B	7.31B	6.1B	5.89B	5.19B
Depreciation & Amortization	n/a	494.8M	518.7M	487.3M	457M	464.6M	650.6M	721.6M	682.7M